FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891607855> ?p ?o ?g. }

• W2891607855 abstract "Background: Pulmonary vascular cell hyperproliferation is characteristic of pulmonary vascular remodeling in pulmonary arterial hypertension. A noninvasive imaging biomarker is needed to track the pathology and assess the response to novel treatments targeted at resolving the structural changes. Here, we evaluated the application of radioligand 3′-deoxy-3′-[18F]-fluorothymidine ( 18 FLT) using positron emission tomography. Methods and Results: We performed dynamic 18 FLT positron emission tomography in 8 patients with idiopathic pulmonary arterial hypertension (IPAH) and applied in-depth kinetic analysis with a reversible 2-compartment 4k model. Our results show significantly increased lung 18 FLT phosphorylation (k 3 ) in patients with IPAH compared with nonpulmonary arterial hypertension controls (0.086±0.034 versus 0.054±0.009 min −1 ; P <0.05). There was heterogeneity in the lung 18 FLT signal both between patients with IPAH and within the lungs of each patient, compatible with histopathologic reports of lungs from patients with IPAH. Consistent with 18 FLT positron emission tomographic data, TK1 (thymidine kinase 1) expression was evident in the remodeled vessels in IPAH patient lung. In addition, hyperproliferative pulmonary vascular fibroblasts isolated from patients with IPAH exhibited upregulated expression of TK1 and the thymidine transporter, ENT1 (equilibrative nucleoside transporter 1). In the monocrotaline and SuHx (Sugen hypoxia) rat pulmonary arterial hypertension models, increased lung 18 FLT uptake was strongly associated with peripheral pulmonary vascular muscularization and the proliferation marker, Ki-67 score, together with prominent TK1 expression in remodeled vessels. Importantly, lung 18 FLT uptake was attenuated by 2 antiproliferative treatments: dichloroacetate and the tyrosine kinase inhibitor, imatinib. Conclusions: Dynamic 18 FLT positron emission tomography imaging can be used to report hyperproliferation in pulmonary hypertension and merits further study to evaluate response to treatment in patients with IPAH." @default.
• W2891607855 created "2018-09-27" @default.
• W2891607855 creator A5000765191 @default.
• W2891607855 creator A5007186540 @default.
• W2891607855 creator A5007376273 @default.
• W2891607855 creator A5009523732 @default.
• W2891607855 creator A5022701632 @default.
• W2891607855 creator A5024488391 @default.
• W2891607855 creator A5025707623 @default.
• W2891607855 creator A5027455541 @default.
• W2891607855 creator A5032825413 @default.
• W2891607855 creator A5047398592 @default.
• W2891607855 creator A5048699691 @default.
• W2891607855 creator A5053967967 @default.
• W2891607855 creator A5064279984 @default.
• W2891607855 creator A5065258380 @default.
• W2891607855 creator A5066375665 @default.
• W2891607855 creator A5066500393 @default.
• W2891607855 creator A5067595969 @default.
• W2891607855 creator A5068191376 @default.
• W2891607855 creator A5089150989 @default.
• W2891607855 date "2018-08-01" @default.
• W2891607855 modified "2023-10-14" @default.
• W2891607855 title "3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung" @default.
• W2891607855 cites W1502612289 @default.
• W2891607855 cites W1866413456 @default.
• W2891607855 cites W1975304410 @default.
• W2891607855 cites W1976017875 @default.
• W2891607855 cites W1979770196 @default.
• W2891607855 cites W1986632212 @default.
• W2891607855 cites W1987934775 @default.
• W2891607855 cites W1987936010 @default.
• W2891607855 cites W2011477996 @default.
• W2891607855 cites W2013425447 @default.
• W2891607855 cites W2014903099 @default.
• W2891607855 cites W2023220164 @default.
• W2891607855 cites W2023455251 @default.
• W2891607855 cites W2024619828 @default.
• W2891607855 cites W2058741232 @default.
• W2891607855 cites W2059868174 @default.
• W2891607855 cites W2060117755 @default.
• W2891607855 cites W2062002285 @default.
• W2891607855 cites W2065501812 @default.
• W2891607855 cites W2072759584 @default.
• W2891607855 cites W2082298563 @default.
• W2891607855 cites W2087628416 @default.
• W2891607855 cites W2095878489 @default.
• W2891607855 cites W2104551495 @default.
• W2891607855 cites W2113711338 @default.
• W2891607855 cites W2124549031 @default.
• W2891607855 cites W2130147370 @default.
• W2891607855 cites W2130697959 @default.
• W2891607855 cites W2133364375 @default.
• W2891607855 cites W2133936093 @default.
• W2891607855 cites W2142635246 @default.
• W2891607855 cites W2147944062 @default.
• W2891607855 cites W2149130975 @default.
• W2891607855 cites W2518911298 @default.
• W2891607855 cites W2546846019 @default.
• W2891607855 cites W2766012717 @default.
• W2891607855 cites W2885921501 @default.
• W2891607855 doi "https://doi.org/10.1161/circimaging.117.007402" @default.
• W2891607855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354494" @default.
• W2891607855 hasPublicationYear "2018" @default.
• W2891607855 type Work @default.
• W2891607855 sameAs 2891607855 @default.
• W2891607855 citedByCount "10" @default.
• W2891607855 countsByYear W28916078552018 @default.
• W2891607855 countsByYear W28916078552020 @default.
• W2891607855 countsByYear W28916078552021 @default.
• W2891607855 countsByYear W28916078552022 @default.
• W2891607855 crossrefType "journal-article" @default.
• W2891607855 hasAuthorship W2891607855A5000765191 @default.
• W2891607855 hasAuthorship W2891607855A5007186540 @default.
• W2891607855 hasAuthorship W2891607855A5007376273 @default.
• W2891607855 hasAuthorship W2891607855A5009523732 @default.
• W2891607855 hasAuthorship W2891607855A5022701632 @default.
• W2891607855 hasAuthorship W2891607855A5024488391 @default.
• W2891607855 hasAuthorship W2891607855A5025707623 @default.
• W2891607855 hasAuthorship W2891607855A5027455541 @default.
• W2891607855 hasAuthorship W2891607855A5032825413 @default.
• W2891607855 hasAuthorship W2891607855A5047398592 @default.
• W2891607855 hasAuthorship W2891607855A5048699691 @default.
• W2891607855 hasAuthorship W2891607855A5053967967 @default.
• W2891607855 hasAuthorship W2891607855A5064279984 @default.
• W2891607855 hasAuthorship W2891607855A5065258380 @default.
• W2891607855 hasAuthorship W2891607855A5066375665 @default.
• W2891607855 hasAuthorship W2891607855A5066500393 @default.
• W2891607855 hasAuthorship W2891607855A5067595969 @default.
• W2891607855 hasAuthorship W2891607855A5068191376 @default.
• W2891607855 hasAuthorship W2891607855A5089150989 @default.
• W2891607855 hasBestOaLocation W28916078551 @default.
• W2891607855 hasConcept C126322002 @default.
• W2891607855 hasConcept C126838900 @default.
• W2891607855 hasConcept C142724271 @default.
• W2891607855 hasConcept C164705383 @default.
• W2891607855 hasConcept C178790620 @default.
• W2891607855 hasConcept C185592680 @default.
• W2891607855 hasConcept C2775842073 @default.
• W2891607855 hasConcept C2777714996 @default.

• next